Matthew Howes was appointed Chief Strategy Officer at The Greater Than One Group (GTO), a privately held, global marketing and communications agency with a proprietary model and focused approach leveraging data, content and media.
If you are not happy with the results below please do another search
50 search results for:
Severe Covid-19 may trick the immune system into producing so-called autoantibodies that have the potential to eventually attack healthy tissue and cause inflammatory diseases, researchers warned in a paper published in Nature Communications. Another study suggests that the virus that causes Covid-19 may be getting better at traveling into the air
Monoclonal antibodies are playing a key therapeutic role in the treatment of some Covid-19 patients, but new research suggests that nanobodies derived from llamas could provide an alternative to monoclonal antibodies through a more effective delivery method—inhalation.
Why aren’t more people getting vaccinated? The answer comes down to a lack of trust, according to the COVID States Project, the largest ongoing national survey tracking people’s opinions and behaviors during the pandemic.
Codagenix Inc. announced favorable safety and immunogenicity data from a Phase I dose-escalation trial of the company’s single-dose intranasal COVI-VAC vaccine, and London-based pHOXBIO Ltd. reported results from a pivotal phase II/III study of the novel prophylactic nasal spray pHOXWELL.
With $19 million in seed funding led by the Retinal Degeneration Fund, Opus Genetics launched with a mission to develop gene therapies for rare forms of blindness driven by genetic mutations.
As a global pandemic has reshaped society, The Bloc has been at the forefront of changing not just what stories get told about healthcare, but how they are told. In doing so, the health creative agency has won more than 200 film and advertising awards during 2020 and 2021.
A potential vaccine from China’s Clover Biopharmaceuticals was 67 percent effective against Covid-19 of any degree of severity and 79 percent against the highly infectious Delta variant in a large trial, the company said on Sept. 22.
The U.S. Food and Drug Administration on Sept. 21 approved Incyte Corp.’s cream Opzelura for treating the inflammatory skin condition atopic dermatitis, commonly called eczema, in adolescents and adults with boxed warnings.
The United States plans to donate an additional 500 million Covid-19 vaccines made by Pfizer Inc. and BioNTech SE to nations around the world, lifting the total the country is sharing to more than 1 billion doses, according to a source familiar with the plans.